PL3328385T3 - Postać dawkowania leku alkaloidu barwinka - Google Patents

Postać dawkowania leku alkaloidu barwinka

Info

Publication number
PL3328385T3
PL3328385T3 PL16832433T PL16832433T PL3328385T3 PL 3328385 T3 PL3328385 T3 PL 3328385T3 PL 16832433 T PL16832433 T PL 16832433T PL 16832433 T PL16832433 T PL 16832433T PL 3328385 T3 PL3328385 T3 PL 3328385T3
Authority
PL
Poland
Prior art keywords
dosage form
vinca alkaloid
alkaloid drug
drug
vinca
Prior art date
Application number
PL16832433T
Other languages
English (en)
Inventor
Subhas Balaram Bhowmick
Prashant Kane
Samarth Kumar
Ramaji Karshanbhai VARU
Nisarg Bipinchandra MISTRY
Swapnil Ramesh PATIL
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of PL3328385T3 publication Critical patent/PL3328385T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
PL16832433T 2015-08-01 2016-08-01 Postać dawkowania leku alkaloidu barwinka PL3328385T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2910MU2015 2015-08-01
PCT/IN2016/050257 WO2017021981A1 (en) 2015-08-01 2016-08-01 Dosage form of vinca alkaloid drug
EP16832433.3A EP3328385B1 (en) 2015-08-01 2016-08-01 Dosage form of vinca alkaloid drug

Publications (1)

Publication Number Publication Date
PL3328385T3 true PL3328385T3 (pl) 2020-12-14

Family

ID=57942574

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16832433T PL3328385T3 (pl) 2015-08-01 2016-08-01 Postać dawkowania leku alkaloidu barwinka

Country Status (6)

Country Link
US (2) US11058679B2 (pl)
EP (2) EP3328385B1 (pl)
JP (2) JP6823045B2 (pl)
ES (1) ES2823281T3 (pl)
PL (1) PL3328385T3 (pl)
WO (1) WO2017021981A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017021981A1 (en) * 2015-08-01 2017-02-09 Sun Pharmaceutical Industries Ltd. Dosage form of vinca alkaloid drug
JP7748616B2 (ja) * 2021-03-24 2025-10-03 大日本印刷株式会社 液体入り組合せ容器、容器セットおよび液体入り容器の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150744A (en) 1976-02-27 1979-04-24 Smith & Nephew Pharmaceuticals Ltd. Packaging
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
ES2097703B1 (es) * 1995-04-12 1997-12-01 Decox S L Una nueva composicion estimulante de la actividad cerebral basada en alcaloides de nucleo de eburnamenina, y sus metodos de preparacion.
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20080113042A1 (en) * 2006-09-05 2008-05-15 Chu Kee Hung Pharmaceutical composition and method for cancer treatment based on combinational use of conventional anticancer agents and geranium oil or compounds thereof
US8742073B2 (en) 2010-05-27 2014-06-03 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
CN203208357U (zh) * 2013-03-20 2013-09-25 山东华鲁制药有限公司 一种新型输液塑料袋包装袋
EP3021811A1 (en) * 2013-07-15 2016-05-25 Alchemia Oncology Pty Limited Method of pre-preparing medications for therapeutic uses
WO2017021981A1 (en) 2015-08-01 2017-02-09 Sun Pharmaceutical Industries Ltd. Dosage form of vinca alkaloid drug

Also Published As

Publication number Publication date
ES2823281T3 (es) 2021-05-06
JP2021073201A (ja) 2021-05-13
US20210308118A1 (en) 2021-10-07
JP2018523658A (ja) 2018-08-23
EP3328385A4 (en) 2019-03-27
US20190008847A1 (en) 2019-01-10
EP3328385B1 (en) 2020-07-08
JP6823045B2 (ja) 2021-01-27
EP3328385A1 (en) 2018-06-06
JP7182651B2 (ja) 2022-12-02
US12178812B2 (en) 2024-12-31
EP3777861A1 (en) 2021-02-17
WO2017021981A1 (en) 2017-02-09
US11058679B2 (en) 2021-07-13

Similar Documents

Publication Publication Date Title
IL287437A (en) Flavociclib solid dosage forms
IL249946B (en) High Dose Strength Rocaprib Tablets
SI4335517T1 (sl) Dajanje in odmerek diaminofenotiazinov
SMT202100444T1 (it) Composizioni farmaceutiche di composti terapeuticamente attivi
ZA201601656B (en) Inhalable pharmaceutical composition
ZA201606075B (en) Pharmaceutical compositions of sitagliptin
IL256115A (en) Pharmaceutical formulations of injectable lapmoline
GB201419540D0 (en) Delivery of drugs
IL267279A (en) Pharmaceutical formulations of suvorexant
IL252080B (en) Oral administration of drugs that are unstable or poorly absorbed
IL251559A0 (en) Pharmaceutical preparations of the history of aminodihydrothiazines from Amano
PL3328385T3 (pl) Postać dawkowania leku alkaloidu barwinka
ZA201902085B (en) Medicinal use of serrulatane diterpenes
IL249374A0 (en) Pharmaceutical administration forms
ZA201500995B (en) Low dose pharmaceutical composition
GB201612863D0 (en) Administration and dosage of diaminophenothiazines
GB201714772D0 (en) Dosage forms of therapeutic compounds
GB201409272D0 (en) Synergistic combination of analgesic drugs